Scientific Presentation
Clonal evolution underlying clinical responses and relapses in subjects with IDH1-mutated AML treated with ivosidenib monotherapy or ivosidenib + azacitidine
Dylan Marchione, PhD
Description
At this year's World CB & CDx conference held in Boston, Dylan Marchione, PhD, of Servier Pharmaceuticals presented data supporting the use of the Tapestri Platform in clinical development to elucidate clonal evolution patterns in patients with IDH1-mutated AML treated with combination therapy, TIBSOVO + azacitidine, as compared to monotherapy.
SHARE THIS PAGE
Scientific Presentations
Interrogating Clonal Evolution in Acute Leukemias through Single-Cell Multi-omic (DNA+Fusion and DNA+Immunophenotype) Analysis
Morgan Drucker, MD
(2025)
Scientific Presentations
Epitope Editing in Hematopoietic Cells Enables Protection From CD45-directed Immunotherapies For The Treatment Of Blood Cancers And HIV Reservoir Elimination
Dr. Nils Wellhausen
(2025)
Scientific Presentations
Leverage Single-cell Multi-parametric Datasets to Advance Heme Oncology Pipelines
Azad Gucwa, PhD
14th World Clinical Biomarkers & Companion Diagnostics Summit (2024)
Scientific Presentations
DKFZ Seminar: Subclonal evolution over the course of quadruplet induction in transplant eligible MM patients
Céline Mazzotti
(2024)